PODD
Insulet Corp Health Care Surgical & Medical Instruments & Apparatus S&P 500Russell 3000
$149.68Close
$10.5BMarket cap
$130.47 – $346.3652-week range
Nov 4, 2026Next report · before the open
Highlights
Strengths
- Earnings growing EPS +330% year on year, faster than the quarter before (+158 pts)
Cautions
- Not in an uptrend 1 of 8 trend conditions
- Lagging the market RS 10 · weaker than 90% of stocks over 12 months
- Far from its high 57% below its 52-week high
- Results soon Nov 4, 2026, in 3 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
57%
1wk
up 0.4%
price change
1mo
up 14.7%
price change
12-month return
down 52%
market up 11% ·
its own down 64%
F-score
6 / 9
Mixed
Altman Z
5.70
Low risk
P/E
42.6×
price / earnings
PEG
—
P/E / EPS growth
P/B
7.0×
price / book
Earnings yield
up 4.4%
EBIT / enterprise value
Cheaper than
46%
of the market · around average
Revenue growth
up 31%
year on year
EPS growth
up 330%
latest quarter · +158 pts
Sales growth
up 24%
latest quarter · -10 pts
ROE
up 18%
return on equity
Free cash margin
up 14%
$377.7M FCF
D/E
0.63
long-term debt / equity
Net debt / EBITDA
0.4×
Interest cover
—EBIT / interest
Piotroski tests
- profitability slipped from last year
- short-term liquidity weakened
- issued more shares
- profitable on its assets
- generating cash from operations
- profits backed by cash
- reduced long-term debt
- gross margin widened
- assets working harder
Repair signals
- Long-term debt down 31% ($1.4B → $0.9B)
- Gross margin 69.8% → 71.6%
Trade setup
ATR%
3.0%
$4.47 a day · 2×ATR $140.73
RS
10 / 99
vs the universe
Trend
1 / 8
trend template
Relative volume
0.7×
vs 50-day average
Up/down volume
1.23
50 sessions
Implied move
12.1%
by Nov 20, 2026 · report Nov 4, 2026
Trend template · 1 of 8
- Price above the 50-day average: passes
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- Interest covered
- No material dilution
- Profits tracking cash
- Margins and revenue not shrinking
Last reported
Aug 5, 2026
Last shock
Aug 5, 2026-20% in one session4.5× volumeon results+12% since
Options
$178,41957.6% IV · activity
Financials
- Gross 72%
- Net 9%
- Free cash 14%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $904.4M | $1.0B | $1.1B | $1.7B | $2.1B | $2.7B |
| Gross margin | 64% | 72% | 76% | 68% | 70% | 72% |
| Operating income | $51.5M | $126.0M | $37.6M | $220.1M | $308.9M | $473.8M |
| Net income | $6.8M | $16.8M | $4.6M | $206.3M | $418.3M | $247.1M |
| Net margin | 1% | 2% | 0% | 12% | 20% | 9% |
| Earnings per share | $0.10 | $0.24 | $0.07 | $2.80 | $5.66 | $3.44 |
| Free cash flow | -$45.0M | -$180.0M | -$3.9M | $70.1M | $305.3M | $377.7M |
| Free cash margin | -5% | -17% | -0% | 4% | 15% | 14% |
| Cash | $907.2M | $806.4M | $689.8M | $704.2M | $953.4M | $716.1M |
| Long-term debt | $1.0B | $1.2B | $1.4B | $1.4B | $1.4B | $949.2M |
| Shareholders' equity | $603.6M | $556.3M | $476.4M | $732.7M | $1.2B | $1.5B |
| Shares outstanding | 66.02m | 69.18m | 69.51m | 69.91m | 70.20m | 70.39m |
Next report
Nov 4, 2026 · before the open
Expected move The move, either way, the option market prices in through the next scheduled report: the at-the-money straddle for the first expiry that contains it, over the price. It includes the days around the report, so it slightly overstates the report alone. Methodology
±12.1%
$132 – $168 by Nov 20, 2026
Usual move The median, over the company's last four reports, of how far the stock moved either way from the close before the filing to the close of the session after it. Methodology
±3.0%
last 4: -16.5% · -4.3% · +1.1% · +1.7%
Expected against usual The move the options price through this report over the move the last four reports delivered. Above 1 the event is priced bigger than the company's own record; below 1, smaller. A price, not a forecast: it says what protection through the report costs, not which way the stock will go. Methodology
Bigger than usual
4.0× the usual move
What options price now
- Swings expected vs recent The daily swings the options are priced for (implied volatility) against the swings the stock actually had over the last 20 sessions (realised volatility). Bigger means options charge for more movement than the stock has been delivering; smaller, less. On a contract row, that contract's own implied volatility over the stock's realised. Methodology
- Bigger 57.6% priced · 30.0% recent
- Next month vs later At-the-money implied volatility for 8-45 day expiries over 46-90 day ones: whether options price the coming month as choppier or calmer than the two after it. Ahead of a report it usually reads choppier, and the extra comes out once the report is out. Methodology
- Choppier
- Crash protection What options that pay off in a fall cost against options that pay off in a rise (the 25-delta skew), compared with this company's own normal - the median of its stored nightly readings, once there are 20 - and with five sessions ago. Protection costs a little more than upside on most shares. More than usual means readers of the chain are paying up to insure against a drop; it does not say which way the stock will go. Methodology
- past week: costs more
Positioning
- Premium traded
- $178,419 calls $154,828 · puts $23,592 · latest session
- 0.15× +0.03 over the week
- Open interest added The change over five sessions in option positions left open overnight, calls and puts. A rise means positions were added. It cannot say whether they were bought or sold, so more calls is not a vote for a rise: a call is as often sold against shares already held. Methodology
- calls +1.43k · puts -69 past week
For options traders: ATM IV 57.6% (+5.9% 1w) · 1m ÷ 3m IV 1.22 · 25Δ skew 4.7 pts · Net GEX $457,478
Most traded contracts
No contract passed the liquidity filters this week.
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 5, 2026 | Quarterly ↗ | Jun 30, 2026 | 36d |
| May 6, 2026 | Quarterly ↗ | Mar 31, 2026 | 36d |
| Feb 18, 2026 | Annual ↗ | Dec 31, 2025 | 49d |
| Nov 6, 2025 | Quarterly ↗ | Sep 30, 2025 | 37d |
| Aug 7, 2025 | Quarterly ↗ | Jun 30, 2025 | 38d |
| May 9, 2025 | Quarterly ↗ | Mar 31, 2025 | 39d |
| Feb 21, 2025 | Annual ↗ | Dec 31, 2024 | 52d |
| Nov 8, 2024 | Quarterly ↗ | Sep 30, 2024 | 39d |
| Aug 9, 2024 | Quarterly ↗ | Jun 30, 2024 | 40d |
| May 10, 2024 | Quarterly ↗ | Mar 31, 2024 | 40d |
| Feb 23, 2024 | Annual ↗ | Dec 31, 2023 | 54d |
| Nov 3, 2023 | Quarterly ↗ | Sep 30, 2023 | 34d |
Current reports
| Filed | Disclosed |
|---|---|
| Sep 21, 2026 | Material agreement · New obligation ↗ |
| Sep 16, 2026 | Director or officer change ↗ |
| Sep 10, 2026 | Director or officer change ↗ |
| Aug 5, 2026 | Results ↗ |
| Jun 25, 2026 | Director or officer change · Regulation FD ↗ |
| May 26, 2026 | Regulation FD ↗ |
| May 21, 2026 | Charter or bylaws · Shareholder vote ↗ |
| May 6, 2026 | Results ↗ |
| Apr 29, 2026 | Regulation FD ↗ |
| Mar 12, 2026 | Regulation FD ↗ |
| Mar 4, 2026 | Director or officer change ↗ |
| Feb 18, 2026 | Results · Regulation FD ↗ |